Literature DB >> 7607646

Detection of a CfoI polymorphism within exon 5 of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4).

O Steinlein1.   

Abstract

The gene coding for the alpha 4 subunit of the neuronal nicotinic acetylcholine receptor (CHRNA4) has been recently mapped in the candidate region for benign familial neonatal convulsions (BFNC) on chromosome 20q13.2-q13.3. The region is only partially covered with polymorphic markers, and so far no PCR-based polymorphisms have been described in the critical region for BFNC. We now report the first polymorphic marker in the coding region of CHRNA4. The new marker, which is detected by PCR, will be useful for evaluation of the role of CHRNA4 as a candidate gene for BFNC. It will further enable the investigation of this important brain-specific gene in association studies with different types of epileptic diseases and other neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607646     DOI: 10.1007/BF00214201

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  1 in total

1.  Refinement of the localization of the gene for neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4) to human chromosome 20q13.2-q13.3.

Authors:  O Steinlein; R Smigrodzki; J Lindstrom; R Anand; M Köhler; C Tocharoentanaphol; F Vogel
Journal:  Genomics       Date:  1994-07-15       Impact factor: 5.736

  1 in total
  2 in total

1.  Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24.

Authors:  H A Phillips; I E Scheffer; K M Crossland; K P Bhatia; D R Fish; C D Marsden; S J Howell; J B Stephenson; J Tolmie; G Plazzi; O Eeg-Olofsson; R Singh; I Lopes-Cendes; E Andermann; F Andermann; S F Berkovic; J C Mulley
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

Review 2.  Genetic influences on smoking: candidate genes.

Authors:  M A Rossing
Journal:  Environ Health Perspect       Date:  1998-05       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.